Lieven Gentaur Advancing RNA Synthesis: Exploring a Next-Generation Transcription Buffer efficient RNA synthesis is a cornerstone of research and development. The tools used for this process must meet rigorous standards to ensure accuracy and effectiveness. One of the latest innovations i... 30 août 2024 News
Lieven Gentaur Enhancing RNA Synthesis Efficiency with Reduced dsRNA By-Products In molecular biology, the synthesis of RNA is a critical process with broad applications, particularly in areas such as in vitro transcription (IVT). Traditionally, wild-type T7 RNA polymerase has bee... 30 août 2024 Our blog
Lieven Gentaur Advancements in Laboratory Illumination Technology In scientific research, accurate illumination and safety are crucial. Laboratories require effective tools for observing experimental results, and advancements in light technology have played a signif... 29 août 2024 News
Lieven Gentaur HEPES-Tris Buffer System for Protein Electrophoresis The HEPES-Tris buffer system is widely recognized for its effectiveness in protein electrophoresis. This buffer system offers superior pH stability, which is crucial for achieving accurate and reprodu... 29 août 2024 Our blog
Lieven Gentaur FDA’s Lykos Rejection Delays—But Doesn’t Stop—Psychedelic Therapies Developers in the psychedelic field remain hopeful despite the FDA’s Complete Response Letter (CRL) issued on August 9 for Lykos Therapeutics’ MDMA-assisted treatment for PTSD. Experts anticipate that... 29 août 2024 News
Lieven Gentaur Efficient Protein Separation with HEPES-Tris Buffer and Advanced Gel Technology In protein electrophoresis, the HEPES-Tris buffer system plays a vital role in enhancing separation efficiency while reducing the overall electrophoresis time. This system is specifically designed to ... 29 août 2024 Our blog
Lieven Gentaur Regeneron Scores EU Lymphoma Approval for Bispecific Antibody Ordspono The European Commission granted approval to Regeneron’s bispecific antibody, Ordspono, on Monday, marking its first regulatory success worldwide. Ordspono is now authorized for treating relapsed or re... 28 août 2024 News
Lieven Gentaur Moderna Lays Foundations for Growth, but Can It Turn Strategy Into Execution? The vaccine manufacturer is up against established competitors in markets that face both demand issues and commercial obstacles, as the biotech seeks to find new avenues for growth. As the 2024–2025 r... 28 août 2024 News
